There are a number of specific phrases, concepts and new organisations associated with the modernisation of health and care but, unless you’re closely involved, it might not always be clear what they refer to.
Here is an explanation of some commonly used terms associated with the changes. If you think any are missing, or if you have heard any that you think need further explanation, please send them in using the comment form at the end of this page.
- A new vision for adult social care
- Appointments Commission
- Arm’s length body (ALB)
- Care Quality Commission (CQC)
- Commissioning development
- Foundation trust (FT)
- GP commissioning consortia, or GP consortia
- GP pathfinders
- Health and Social Care Bill
- Health and wellbeing boards
- Health Education England
- Health Protection Agency (HPA)
- Local Involvement Networks (LINks)
- Local democratic legitimacy
- National Treatment Agency (NTA)
- NHS Commissioning Board
- NHS White Paper
- NICE (National Institute for Health and Clinical Excellence)
- Outcomes /outcomes framework
- Patient revolution
- Provider development
- Provider Development Authority
- Public Health England (PHE)
- Public health observatories (PHOs)
- Public Health White Paper
- Ring-fenced budgets
A new vision for adult social care: The Department published A vision for adult social care: capable communities and active citizens on 16 November 2010. It sets out the Government’s ambition to make services more personalised, more preventative and more focused on delivering the best outcomes for those who use them. The Department also published a consultation on a new strategic approach to quality and outcomes in adult social care – Transparency in outcomes: a framework for adult social care.
Appointments Commission: An independent organisation responsible for appointing chairs and non-executives to strategic health authorities, primary care trusts, NHS trusts and the Department’s arm’s length bodies. It also provides non-executive recruitment services for foundation trusts and to the boards of public bodies across central Government.
Arm’s length body: As stand-alone national organisations sponsored by the Department of Health, arm’s length bodies (ALBs) work closely with the local NHS, social care services, and other ALBs to carry out specific functions. In the Department of Health they regulate the system, improve standards, protect public welfare and support local services.
Commissioning: Commissioning is the buying of health and care services. It is a continuous cycle of activities that includes agreeing and specifying services to be delivered over the long term through partnership working, as well as contract negotiation, target setting, providing incentives and monitoring. It is all about making sure that health and care services effectively meet the needs of a given population with the resources available.
Foundation trust: Foundation trusts are NHS providers who achieve foundation trust status, which means they have greater freedoms and are subject to less central control, enabling them to be more responsive to the needs of local populations.
GP commissioning consortia, or GP consortia: Groups of GPs that will be responsible for buying health and care services for patients, taking over the role from primary care trusts. They will implement the new commissioning roles as set out in the White Paper Equity and excellence: Liberating the NHS.
GP pathfinders: The first groups of GP commissioning consortia who have shown that they would like to move quickly to implement the new commissioning roles. The pathfinders consortia will test concepts, themes and functions at an early stage.
Health and Social Care Bill: The Health and Social Care Bill creates the legislative framework for the NHS as set out, and consulted on, in the White Paper Equity and excellence: Liberating the NHS. It devolves power in the NHS, clarifying roles and responsibilities so that everyone can enjoy better quality health care and better health.
Health and wellbeing boards: These are being set up in local authorities to improve health and care services, and the health and wellbeing of local people. They will bring together the key commissioners in an area, including representatives of GP consortia, directors of public health, children’s services and adult social services, with at least one elected councillor and a representative of Healthwatch. The boards will assess local needs and develop a shared strategy to address them, providing a strategic framework for individual commissioners’ plans. Shadow health and wellbeing boards will be in place in each local authority by April 2012 and, subject to Parliamentary approval, will be established from 2013.
Health Education England: Subject to consultation, Health Education England will be established as a special health authority during 2011-12 to provide sector-wide leadership for workforce planning, education and training. It will be accountable to the Department through a framework agreement and sponsorship arrangements.
Health Protection Agency (HPA): The Agency reduces the dangers to health from infections, chemical and radiation hazards, and works in partnership with other organisations who have health protection responsibilities. The functions of the HPA will eventually be incorporated in to those of Public Health England.
Healthwatch: A new patient champion being established in April 2012. It will ensure that patients are involved in decisions about their care and that their views are considered when providers commission services.
Local democratic legitimacy: Local democratic legitimacy in health is the Government’s intention to give more of a voice to local people, by involving local councillors and patient representatives in shaping and influencing the strategic direction of the health and social care system in their area. See also ‘Health and wellbeing boards’.
Monitor: An executive non-departmental public body that will become the economic regulator for health and social care, operating a joint licensing regime with the Care Quality Commission. It will regulate prices, promote competition and prevent anti-competitive behaviour. (Monitor currently authorises and regulates NHS foundation trusts.)
National Treatment Agency (NTA): The NTA improves the availability, capacity and effectiveness of drug treatment in England. The functions of the NTA will eventually be incorporated in to those of Public Health England.
NHS Commissioning Board: This Board will sit at arm’s length from the government and will oversee local GP consortia. It will make sure that consortia have the capacity and capability to commission successfully and meet their financial responsibilities. It will also commission some services directly. The Board will exist in shadow form from June 2011.
NHS White Paper: This usually refers to the July 2010 White Paper Equity and excellence: Liberating the NHS. It sets out the Government strategy for the NHS.
NICE (National Institute for Health and Clinical Excellence): An independent organisation providing advice and guidelines on the cost and effectiveness of drugs and treatments. The role of NICE will be significantly extended.
Outcomes /outcomes framework: Broadly speaking, ‘outcomes’ means ‘results’. The NHS Outcomes Framework sets out the results that the Secretary of State will expect the NHS Commissioning Board to deliver once it is established. The Public Health Outcomes Framework promotes joint working where local organisations share common goals.
Pathfinders: See GP pathfinders
Provider development: This phrase refers to the way in which NHS providers (eg physiotherapists) will be given more freedom to help them deliver the best possible care for patients, and to make it easier for new providers to offer services. Hospitals that perform well will get more money to develop their services. Performance will be measured by whether patients’ health and wellbeing improves rather than by targets. For example, instead of performance being measured against waiting times, it would be measured against things such as how many patients who suffer a stroke are able to live independently.
Provider Development Authority: The Provider Development Authority will provide central support to enable remaining NHS trusts to become foundation trusts. It will take on responsibility from the Department and strategic health authorities during 2011–12 and hold NHS trusts to account. The intention is that the Provider Development Authority will continue in its role until 31 March 2014.
Public Health England: This is the new public health service outlined in the White Paper Healthy lives, healthy people: our strategy for public health in England. Public Health England will be part of the Department of Health and will incorporate the current functions of the Health Protection Agency and the National Treatment Agency for Substance Misuse (subject to the Health and Social Care Bill being passed in Parliament). It is intended that Public Health England will lead health protection and set the overall outcomes framework for public health.
Public health observatories (PHOs): There are nine regional PHOs across England. They produce information, data and intelligence on people’s health and health care for practitioners, policy makers and the wider community. Their information and intelligence functions are due to transfer into Public Health England.
Public Health White Paper: This usually refers to the November 2010 White Paper Healthy lives, healthy people: our strategy for public health in England.
Ring-fenced budgets: These are public health budgets that will be allocated to local authorities from April 2013 for their new role in public health. The Department will set out the purpose of the funding but not exactly how the money should be spent. Local authorities will be able to use the ring-fenced budget widely to improve public health in their local area in line with local priorities. This may include using it jointly with other local authority budgets such as those for children’s service, schools, housing, transport and environmental health.